| April 25 (Fri) Hall A | ||
|---|---|---|
| SESSION Best Oral Presentation | Sooyoung Hur (The Catholic University of Korea) Jeong-Won Lee (Sungkyunkwan University) |
|
| 08:30-08:40 |
Impact of neoadjuvant chemotherapy (NAC) combined with durvalumab and tremelimumab on the tumour Immune microenvironment in advanced ovarian cancer: translational analyses from the TRU-D/KGOG 3046 study
|
Junsik Park (Soonchunhyang University) |
| 08:40-08:45 |
Designated discussion
|
Taehun Kim (Seoul National University) |
| 08:45-08:55 |
Integrative spatial and transcriptomic profiling reveals novel prognostic clusters in cervical cancer
|
Jong Mi Kim (Kyungpook National University) |
| 08:55-09:00 | Designated discussion
|
Eun Bi Jang (Konkuk University) |
| 09:00-09:10 |
A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer (NIVEC)
|
Yong Jae Lee (Yonsei University) |
| 09:10-09:15 | Designated discussion
|
Soo Hyun Oh (Gachon University) |
| 09:15-09:25 |
Utility of the CA125 KELIM in for predicting the Benefit of from HIPEC in patients with advanced ovarian cancer: Pooled analysis of Individual data from KGOG3042 and KOV-HIPEC-01
|
Hyun-Woong Cho (Korea University) |
| 09:25-09:30 | Designated discussion
|
Soo Young Jeong (Hallym University) |
| 09:30-10:00 | Opening Ceremony | Hall A/B/C |
| 09:30-10:00 | Welcome Remark
|
Jae-Kwan Lee (President of KSGO) |
| 2025 - 2026 KSGO Board of Directors | ||
| 2025 New Gynecologic Oncologist of KSGO | Eun Bi Jang (Konkuk University) Jimin Lee (Ajou University) Mia Park (Chungnam National University) Ji Hyun Lee (Yonsei University) |
|
| KSGO Appreciation Award | Jae-Weon Kim (Past President of KSGO) Hee Seung Kim (Past Secretary General of KSGO) |
|
| KSGO Achievement Award | Suk-Joon Chang (KSGO 40th Anniversary Project Subcommittee Chair) Nam Kyeong Kim (KSGO 40th Anniversary Project Subcommittee Administrative Coordinator) |
|
| Introduction of KSGO International Conference 2025 | Suk-Joon Chang (Chair of Scientific Program Committee) |
|
| SESSION Scientific Session I (Ovarian Cancer) | Young Tae Kim (Yonsei University) Yoichi Kobayashi (Kyorin University) |
|
| 10:00-10:20 | Role of secondary cytoreductive surgery for recurrent ovarian cancer in the era of PARPi
|
Christina Fotopoulou (Imperial College London) |
| 10:20-10:25 | Designated discussion
|
Hyeong In Ha (NHIC Ilsan Hospital) |
| 10:25-10:30 | Floor discussion | |
| 10:30-10:50 | Updated ovarian cancer trials in China
|
Rongyu Zang (Zhongshan Hospital) |
| 10:50-10:55 | Designated discussion
|
Shin-Wha Lee (University of Ulsan) |
| 10:55-11:00 | Floor discussion | |
| 11:00-11:20 | Next horizon in ovarian cancer: Evolving clinical trials and translational research
|
Jung-Yun Lee (Yonsei University) |
| 11:20-11:25 | Designated discussion
|
Sung Jong Lee (The Catholic University of Korea) |
| 11:25-11:30 | Floor discussion | |
| SESSION Industry Session I - BORYUNG | Taek Sang Lee (Seoul National University) |
|
| 12:20-12:40 | Latest knowledge of 2nd generation G-CSF in gynecological cancer (Neulasta)
|
Joseph Noh (Seoul National University) |
| 12:40-12:50 | Floor Discussion | |
| SESSION Collaborative Session: Current Status of Gynecologic Cancer Treatment in China (CSGO) | Beihua Kong (Qilu Hospital of Shandong University) Jae-Kwan Lee (Korea University) |
|
| 13:00-13:15 | The laparoscopic surgery for early stage of cervical cancer: What is the future?
|
Yang Xiang (PUMC Hospital) |
| 13:15-13:20 | Designated discussion
|
Seung Hyuk Shim (Konkuk University) |
| 13:20-13:35 | The fertility sparing treatment for endometrium cancer in China
|
Yiqin Wang (Peking University People's Hospital) |
| 13:35-13:40 | Designated discussion
|
Jeong-Yeol Park (University of Ulsan) |
| 13:40-13:55 | Ovarian cancer trials in China
|
Rongyu Zang (Zhongshan Hospital) |
| 13:55-14:00 | Designated discussion
|
Jae Yun Song (Korea University) |
|
SESSION Live Surgery-Ovarian Cancer
|
Suk-Joon Chang (Ajou University) Christina Fotopoulou (Imperial College London) Yoo-Young Lee (Sungkyunkwan University) |
|
| 14:20-17:20 | Primary cytoreductive surgery for ovarian cancer | Phillip Harter (Ev. Kliniken Essen-Mitte) |
| Interval cytoreductive surgery for ovarian cancer | Sang Yoon Park (National Cancer Center) |
|
| Robot hybrid cytoreductive surgery | Myong Cheol Lim (National Cancer Center) |
|
| April 25 (Fri) Hall B | ||
| SESSION Collaborative Session: Current Status of Gynecologic Cancer Treatment in Japan (JSGO) | Aikou Okamoto (Jikei University) Jae-Weon Kim (Seoul National University) |
|
| 11:00-11:15 | Cervical cancerHideki
|
Tokunaga (Tohoku University) |
| 11:15-11:20 | Designated discussion
|
Eun Ji Nam (Yonsei University) |
| 11:20-11:35 | Endometrial cancer
|
Tohru Morisada (Kyorin University) |
| 11:35-11:40 | Designated discussion
|
Banghyun Lee (Inha University) |
| 11:40-11:55 | Ovarian cancer
|
Tsukasa Baba (Iwate Medical University) |
| 11:55-12:00 | Designated discussion
|
Sang Hun Lee (University of Ulsan) |
| SESSION Industry Session II - MSD | Sang Wun Kim (Yonsei University) |
|
| 12:20-12:40 | Breaking endometrial cancer, building a patient's life: The role of pembrolizumab in both pMMR and dMMR (KEYNOTE-868/NRG-GY018)
|
Yoo-Young Lee (Sungkyunkwan University) |
| 12:40-12:50 | Floor Discussion | |
| SESSION Collaborative Session: Current Status of Gynecologic Cancer Treatment in Indonesia (INASGO) | Yudi Mulyana Hidayat (Hasan Sadikin General Hospital Bandung) Tae-Wook Kong (Ajou University) |
|
| 13:00-13:15 | Epidemiology of gynecologic cancer in Indonesia: Shifting cancer burden to the young population
|
Yudi Mulyana Hidayat (Hasan Sadikin General Hospital Bandung) |
| 13:15-13:20 | Designated discussion
|
Heon Jong Yoo (Chungnam National University) |
| 13:20-13:35 | Optimizing gynecologic cancer management in Indonesia: Addressing disparities and enhancing surgical skills
|
Brahmana Askandar (Airlangga University) |
| 13:35-13:40 | Designated discussion
|
San Hui Lee (Yonsei University Wonju) |
| 13:40-13:55 | Future directions in diagnostics and therapy for gynecologic cancer in Indonesia: Implementing molecular testing and targeted therapies
|
Tricia Dewi Angggraeni (Universitas Indonesia) |
| 13:55-14:00 | Designated discussion
|
Hyunji Lim (Seoul National University) |
| April 25 (Fri) Hall C | ||
| SESSION Industry Session III - HK inno.N | Sokbom Kang (National Cancer Center) |
|
| 12:20-12:40 | The optimal treatment strategy for front-line ovarian cancer management
|
Hyung Joon Yoon (Pusan National University) |
| 12:40-12:50 | Floor Discussion | |
| SESSION Mini-Oral I | Yong Beom Kim (Seoul National University) Dong Choon Park (The Catholic University of Korea) |
|
| 13:00-13:04 | Characterization of humanized mouse model for evaluating immunotherapy in ovarian cancer
|
Sung Wan Kang (Asan Medical Center) |
| 13:04-13:08 | Discussion | |
| 13:08-13:12 | Is consolidation therapy effective in patients with early endometrioid endometrial cancer achieving complete remission for fertility-sparing hormonal treatment?
|
Eun Bi Jang (Konkuk University Medical Center) |
| 13:12-13:16 | Discussion | |
| 13:16-13:20 | Microbial metabolites control self-renewal and precancerous progression of human cervical stem cells
|
Hee Yeun Yoon (Kyungpook National University) |
| 13:20-13:24 | Discussion | |
| 13:24-13:28 | Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer: a phase III, double-blind, randomized study
|
Hee Seung Kim (Seoul National University) |
| 13:28-13:32 | Discussion | |
| 13:32-13:36 | Clinical impact of first-line maintenance therapy agents on survival outcomes in ovarian cancer patients stratified by homologous recombination status
|
Young Joo Lee (Kyung Hee University) |
| 13:36-13:40 | Discussion | |
| 15:00-17:05 | Hall C | |
| SESSION Collaborative Session: AOGIN | Yong-Man Kim (University of Ulsan) |
|
| Part 1: Current Issues in Cervical Cancer Screening and Management | ||
| 15:00-15:20 | Cervical cancer screening based on HPV test
|
Shin-Wha Lee (University of Ulsan) |
| 15:20-15:40 | Implementation of primary HPV screening and self-sampling in Thailand
|
Wichai Termrungruanglert (Chulalongkorn University) |
| 15:40-16:00 | The role of extended genotyping in cervical cancer elimination
|
Tessa Riandini (Becton, Dickinson and Company) |
| 16:00-16:10 | Discussion
|
|
| Young-Tak Kim (CHA University) |
||
| Part 2: Position Statement and Campaign of International Societies | ||
| 16:10-16:35 | Benefits for Asian societies in IPVC 2025 and AI in cervical cancer screening and management
|
Siriwan Tangjitgamol (Vajira Hospital) |
| 16:35-16:55 | Global cervical cancer awareness campaign
|
Hyo Sook Bae (For C Campaign.org) |
| 16:55-17:05 | Discussion
|
|
| April 25 (Fri) Hall D | |||
|---|---|---|---|
| SESSION E-poster Session | Line 1 - Dae Hoon Jeong (Inje University) Line 2 - Gun Oh Chong (Kyungpook National University) Line 3 -Eun-Ju Lee (Chung-Ang University) |
||
| 13:40-13:45 | Effects of metabolic risk score on treatment decision for endometrial cancer: establishment of a machine learning-based predictive model for survival Jingyuan Wang (Peking University) |
Does HRD score predict response and survival outcomes to platinum-based neoadjuvant chemotherapy? Uisuk Kim (National Cancer Center) |
Oregovomab in combination with non-platinum chemotherapy for the treatment of PARP inhibitor- and platinum-resistant ovarian cancer: a two-cohort, single-arm phase 2 study (OPERA/KGOG3065/APGOT-OV6) Junsik Park (Soonchunhyang University) |
| 13:45-13:47 | Discussion | Discussion | Discussion |
| 13:47-13:52 | vNOTES hysterectomy with sentinel node dissection Edvard Berg (Bashkir State Medical University) |
Prognosis of patients who become pregnancy after achieving a complete response with fertility-sparing treatment in early endometrial cancer: Gynecologic oncology research investigators coLLaborAtion study (GORILLA-3001) A Jin Lee (Ilsan Cha Hospital) |
Outcomes of laparoscopic resection for pelvic recurrence of endometrial cancer: A single-center retrospective study Risako Ozawa (Cancer Institute Hospital of JFCR) |
| 13:52-13:54 | Discussion | Discussion | Discussion |
| 13:54-13:59 | Surgical indications for residual and recurrent cervical cancer after radiation therapy Mayumi Kamata (Cancer Institute Hospital of JFCR) |
Prognostic impact of primary surgery in human papillomavirus-independent, advanced or metastatic endocervical adenocarcinoma: A bi-institutional retrospective study Jun-Hyeong Seo (Sungkyunkwan University) |
Landscape of genomic alterations and clinical outcomes in low-grade serous ovarian cancer in Korea Ji Hyun Kim (National Cancer Center) |
| 13:59-14:01 | Discussion | Discussion | Discussion |
| 14:01-14:06 | Challenges facing female gynecologic oncology professionals in their career development: Results from the survey of Asian countries Ga Won Yim (Dongguk University Medical Center) |
Postoperative early morbidity and mortality outcomes of primary and interval cytoreductive surgery for advanced epithelial ovarian cancer; A Korean gynecologic oncologic group (KGOG 4005/4006) Heon Jong Yoo (Chung-Ang University) |
Value of systematic lymphadenectomy in early stage, high grade epithelial ovarian cancer, in the era of modern imaging Minah Ha (Te Whatu Ora Health New Zealand) |
| 14:06-14:08 | Discussion | Discussion | Discussion |
| 14:08-14:13 | Monocytes as potential predictors of immune-related adverse events (irAEs) in cancer patients receiving immune checkpoint inhibitors Ayumi Shikama (University of Tsukuba) |
A domestic exchange program for gynecologic oncology doctors in Japan Hiroko Matsumiya (Hokkaido University Hospital) |
Clinical significance of claudin18 in gastric adenocarcinoma of the cervix Fumimasa Osone (The Jikei University Hospital) |
| 14:13-14:15 | Discussion | Discussion | Discussion |
| 14:15-14:20 | Clinical features’ differences between CA-125 and RECIST progression in ovarian cancer patients treated with poly (ADP-ribose) polymerase inhibitors Yana Ma (Qilu hospital of Shandong University) |
Hyperthermia-Induced sensitization of cisplatin-resistant ovarian cancer cells: A potential strategy for overcoming drug resistance Joo-Hyuk Son (Ajou University) |
Survival outcomes of postoperative chemotherapy versus concurrent chemoradiotherapy followed by chemotherapy in advanced endometrial cancer Aeran Seol (Seoul National University) |
| 14:20-14:22 | Discussion | Discussion | Discussion |
| 14:22-14:27 | Impact of primary radical surgery on survival outcomes in patients with locally advanced HPV-independent endocervical adenocarcinoma Hyunji Lim (Seoul National University) |
GLDC promotes cisplatin resistance of ovarian cancer cells by enhancing ROS-driven mitochondrial fission Seungmee Lee (Keimyung University) |
Pattern of care study for radiotherapy of recurrent ovarian cancer patients among gynecologic and radiation oncologists in Korea Bo Ra Kim (Ewha Womans University Medical Center) |
| 14:27-14:29 | Discussion | Discussion | Discussion |
| April 25 (Fri) Hall E | |||
|---|---|---|---|
| SESSION Surgical Film Screening | |||
| SF-02 | A comprehensive guide to vNOTES pelvic lymphadenectomy in early-stage endometrial cancer | Sujin Lee (Seoul ST. Mary’s Hospital) |
|
| SF-03 | How to use the indocyanine green after sentinel lymph node biopsy during staging surgery | Won Moo Lee (Hanyang University) |
|
| SF-04 | Robotic primary staging surgery in stage IIIA ovarian cancer | Seon-Mi Lee (Korea University Anam Hospital) |
|
| SF-05 | Early experience of DV5 system for endometrial cancer using lower pelvic port placement | Seongmin Kim (Korea University Anam Hospital) |
|
| April 26 (Sat) Hall A | |||
| SESSION Industry Session VII - Chong Kun Dang | Yong Beom Kim (Seoul National University) |
||
| 08:00-08:30 | New insight into strategies used to long-acting G-CSF for prevention of neutropenia
|
Jeong-Yeol Park (University of Ulsan) |
|
| 08:30-08:40 | Floor discussion
|
||
| SESSION Scientific Session II (Endometrium) | Byoung-Gie Kim (Sungkyunkwan University) Sang Hoon Kwon (Keimyung University) |
||
| 09:30-09:50 | Role of adjuvant therapy in early-stage endometrial cancer
|
Philipp Harter (Ev. Kliniken Essen-Mitte) |
|
| 09:50-09:55 | Designated discussion
|
Yung-Taek Ouh (Korea University) |
|
| 09:55-10:00 | Floor discussion
|
||
| 10:00-10:20 | Innovations in molecular subtyping for precision medicine
|
Tadaaki Nishikawa (The Jikei University) |
|
| 10:20-10:25 | Designated discussion
|
Angela Cho (Jeju National University) |
|
| 10:25-10:30 | Floor discussion
|
||
| 10:30-10:50 | Importance of follow-up of patients with uterine corpus cancer from the perspective of cardio-oncology
|
Yoichi Kobayashi (Kyorin University) |
|
| 10:50-10:55 | Designated discussion
|
Yu-Jin Koo (Yeungnam University) |
|
| 10:55-11:00 | Floor discussion
|
||
| 11:00-11:20 | Durvalumab plus carboplatin/paclitaxel followed by durvalumab with/without Olaparib in endometrial cancer: Biomarkers, histological heterogeneity, baseline circulating tumor DNA levels, and efficacy in the DUO-E mismatch repair proficient subpopulation
|
Jae-Weon Kim (Seoul National University) |
|
| 11:20-11:25 | Designated discussion
|
Jin Hwa Hong (Korea University) |
|
| 11:25-11:30 | Floor discussion
|
||
| SESSION Industry Session IV - GSK | Dae-Yeon Kim (University of Ulsan) |
||
| 11:50-12:10 | Illuminating advances: Transformative role of dostarlimab in advanced/recurrent endometrial cancer treatment
|
Hee-Seung Kim (Seoul National University) |
|
| 12:10-12:20 | Floor discussion
|
||
| SESSION Tumor Board: Multinational Tumor Board on Gynecologic Cancer: Exploring Treatment Landscapes | Yoo-Young Lee (Sungkyunkwan University) |
||
| 12:50 - 14:20 | Panel(s)
|
Siriwan Tangjitgamol (Vajira Hospital) Won Kyung Cho (Sungkyunkwan University) Tricia Dewi Angggraeni (Universitas Indonesia) Hiroyuki Kanao (Cancer Institute Hospital) Jen-Ruei Chen (MacKay Memorial Hospital) Yang Xiang (PUMC Hospital) |
|
| SESSION Debate Session | Jeong-Yeol Park (University of Ulsan) |
||
| Optimal surgical approach for early-stage cervical cancer | |||
| 14:40-14:52 | Favor minimally invasive surgery
|
Yang Xiang (PUMC Hospital) |
|
| 14:52-15:04 | Favor open surgery
|
Philipp Harter (Ev. Kliniken Essen-Mitte) |
|
| 15:04-15:10 | Discussion
|
Seung Hyuk Shim (Konkuk University) |
|
| How to improve survival outcome in locally advanced cervical cancer | |||
| 15:10-15:22 | Favor addition of neoadjuvant chemotherapy or immune check point inhibitor to CCRT
|
Christina Fotopoulou (Imperial College London) |
|
| 15:22-15:34 | Favor addition of debulking surgery to CCRT
|
Ju-Won Roh (CHA University) |
|
| 15:34-15:40 | Discussion
|
Sunmin Park (Korea University) |
|
| Optimal management of recurrent cervical cancer in irradiated pelvis | |||
| 15:40-15:52 | Favor surgical management including pelvic exenteration
|
Hiroyuki Kanao (Cancer Institute Hospital) |
|
| 15:52-16:04 | Favor non-surgical management
|
Jen-Ruei Chen (MacKay Memorial Hospital) |
|
| 16:04-16:10 | Discussion
|
Hee Seung Kim (Seoul National University) |
|
| April 26 (Sat) Hall B | |||
| SESSION Collaborative Session: Current Status of Gynecologic Cancer Treatment in Thailand (TGCS) | Perapong Inthasorn (Mahidol University) Rakchai Buhachat (Prince of Songkhla University) |
||
| 09:30-09:45 | Endometrial cancer
|
Atthapon Jaishuen (Mahidol University) |
|
| 09:45-09:50 | Designated discussion
|
Seongmin Kim (Korea University) |
|
| 09:50-10:05 | Ovarian cancer
|
Kamaitorn Tientong (Rajavithi Hospital) |
|
| 10:05-10:10 | Designated discussion
|
Yoon Hee Lee (Kyungpook National University) |
|
| 10:10-10:25 | Cervical cancer
|
Panwad Ratanasrithong (National Cancer Institute of Thailand) |
|
| 10:25-10:30 | Designated discussion
|
Seungho Lee (Gachon University) |
|
| SESSION Collaborative Session: Current Status of Gynecologic Cancer Treatment in Taiwan (TAGO) | Cheng-Chang Chang (China Medical University Hospital) Kung-Liahng Wang (Mackay Memorial Hospital) |
||
| 10:30-10:45 | Focusing on the recent progress of the three major gynecological cancers from a clinical perspective in Taiwan
|
Peng-Hui Wang (Taipei Veterans General Hospital) |
|
| 10:45-10:50 | Designated discussion
|
Won Moo Lee (Hanyang University) |
|
| 10:50-11:05 | Experience sharing about hyperthermic intraperitoneal chemotherapy for ovarian, fallopian tubal and primary peritoneal cancers in a tertiary referral medical center in Taiwan
|
Jen-Ruei Chen (MacKay Memorial Hospital) |
|
| 11:05-11:10 | Designated discussion
|
Sanghoon Lee (Korea University) |
|
| 11:10-11:25 | Fallopian tube organoids: A novel approach for the discovery of early copy number alterations of high-grade serous ovarian cancer
|
Hung-Cheng Lai (Taipei Medical University) |
|
| 11:25-11:30 | Designated discussion
|
Eun Jung Yang (Soonchunhyang University) |
|
| SESSION Industry Session V - Takeda | Jae-Weon Kim (Seoul National University) |
||
| 11:50-12:10 | Exploring optimal PARP inhibitor treatment in advanced ovarian cancer
|
Bradley Monk (Florida Cancer Specialists and Research Institute) |
|
| 12:10-12:20 | Floor discussion | ||
| SESSION Collaborative session: KGOG - For the Glory of KGOG and KSGO | Jae Hoon Kim (Yonsei University) |
||
| 12:50-13:00 | Beginning and past of KGOG: Foundations of progress
|
Yong-Man Kim (University of Ulsan) |
|
| 13:00-13:10 | KGOG Today: Advancing gynecologic oncology
|
Dae-Yeon Kim (University of Ulsan) |
|
| 13:10-13:20 | Cervical cancer innovations: KGOG-led studies and outcomes
|
Sang Wun Kim (Yonsei University) |
|
| 13:20-13:30 | Endometrial cancer insights: KGOG-led research contributions
|
Jeong-Yeol Park (University of Ulsan) |
|
| 13:30-13:40 | Ovarian cancer breakthroughs: Spotlight on KGOG-led studies
|
Chel Hun Choi (Sungkyunkwan University) |
|
| 13:40-13:50 | Overview of the 400X protocol: Insights from the surgery and DDT committee
|
Eun-Ju Lee (Chung-Ang University) |
|
| 13:50-14:00 | Collaborating for progress: KGOG’s role in NRG studies
|
Min Kyu Kim (Sungkyunkwan University) |
|
| 14:00-14:10 | Expanding horizons: KGOG's participation in GOG-partners research
|
Jae Yun Song (Korea University) |
|
| 14:10-14:20 | Global collaboration in gynecologic Oncology: KGOG in ENGOT, JGOG, and EAGOT initiatives
|
Min Chul Choi (University of Ulsan) |
|
| SESSION Collaborative Session: KGCR - Innovations in Gynecological Cancer Translational Research: Current Trends and Future Directions | Yoo-Young Lee (Sungkyunkwan University) Yusuke Kobayashi (University of Tsukuba) |
||
| 14:40-15:00 | Translational research approaches utilizing PDX and PDO models in gynecologic cancer
|
Jeong-Won Lee (Sungkyunkwan University) |
|
| 15:00-15:20 | Development of novel personalized medicine for ovarian clear cell carcinoma
|
Shogo Shigeta (Tohoku University) |
|
| 15:20-15:40 | Therapy of drug resistant ovarian cancer
|
Jaeho Kim (Pusan National University) |
|
| 15:40-16:00 | New findings of basic research on PARP and functional analysis of SLFN11 related to therapeutic effect of PARP inhibitors
|
Junko Murai (Ehime University) |
|
| 16:00-16:10 | Discussion | ||
| April 26 (Sat) Hall C | |||
| SESSION JGO Workshop: Appropriate Use of AI in Writing and Reviewing Scientific Papers | Siriwan Tangjitgamol (Vajira Hospital) Hidemichi Watari (Hokkaido University) |
||
| 08:30-08:50 | AI-empowered manuscript writing
|
Yusuke Kobayashi (University of Tsukuba) |
|
| 08:50-09:10 | Case study: AI application
|
Dong Hoon Suh (Seoul National University) |
|
| 09:10-09:30 | Q&A
|
||
| SESSION Mini-Oral II | Seob Jeon (Soonchunhyang University) Chul Min Park (Jeju National University) |
||
| 10:00-10:04 | Intratumor microbiome-derived butyrate facilitates progestin resistance by inducing ferroptosis in endometrial cancer | Xingchen Li (Peking University) |
|
| 10:04-10:08 | Discussion | ||
| 10:08-10:12 | Survival outcomes of PCS vs. ICS in advanced ovarian cancer according to institutional criteria during the TRUST trial enrollment period
|
Jae Kyung Bae (National Cancer Center) |
|
| 10:12-10:16 | Discussion | ||
| 10:16-10:20 | Histopathologic validation of 2023 FIGO stage IA1–IIIC2 endometrial carcinoma: A retrospective analysis of two tertiary centers in South Korea and Taiwan
|
Myeong-Seon Kim (Chung-Ang University) |
|
| 10:20-10:24 | Discussion | ||
| 10:24-10:28 | Updates on prospective multi-institutional phase III trial of standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC, KGOG 3064/KROG 2204)
|
Sangjoon Park (Yonsei Cancer Center) |
|
| 10:28-10:32 | Discussion | ||
| 10:32-10:36 | The Forkhead box protein A1 gene exhibits oncogenic properties in ovarian cancer and can serve as a diagnostic biomarker
|
Eunjung Yang (Soonchunhyang University) |
|
| 10:36-10:40 | Discussion | ||
| SESSION Mini-Oral III | Ki Hyung Kim (Pusan National University) Ju-Won Roh (CHA University) |
||
| 10:40-10:44 | Evaluation for risk factors against expectant management in cervical intraepithelial neoplasia: A multicenter real-world cohort study
|
Heekyoung Song (The Catholic University of Korea) |
|
| 10:44-10:48 | Discussion | ||
| 10:48-10:52 | Survival implications of sarcopenia in epithelial ovarian cancer patients undergoing bowel surgery
|
Jihye Kim (Chung-Ang University Hospital) |
|
| 10:52-10:56 | Discussion | ||
| 10:56-11:00 | Type-specific risk of high-risk human papillomavirus (HR-HPV) for cervical intraepithelial neoplasia 2 or worse in HR-HPV positive women with mildly abnormal cervical cytology
|
Min-Jeong Kim (Cha University) |
|
| 11:00-11:04 | Discussion | ||
| 11:04-11:08 | Effectiveness of HPV vaccination across age groups: The Korean HPV cohort study
|
Sanha Lee (The Catholic University of Korea) |
|
| 11:08-11:12 | Discussion | ||
| 11:12-11:16 | The value of the naples prognostic score as a predictor of cancer progression in cervical cancer
|
Seon Mi Lee (Korea University) |
|
| 11:16-11:20 | Discussion | ||
| SESSION Industry Session VI - Roche Diagnostics | Jae Hong No (Seoul National University) |
||
| 11:50-12:10 | The new paradigm (CINtec PLUS): Dual stain triage for cervical cancer screening
|
Heekyoung Song (The Catholic University of Korea) |
|
| 12:10-12:20 | Floor discussion
|
||
| SESSION Young Investigator Session | Sunghoon Kim (Yonsei University) Myong Cheol Lim (National Cancer Center) |
||
| 12:50-12:57 | Clinical application of circulating tumor DNA for tumor profiling and monitoring in high-grade serous ovarian cancer
|
Se Ik Kim (Seoul National University) |
|
| 12:57-13:00 | Discussion | ||
| 13:00-13:07 | A multicenter study of laparoscopic versus laparotomic surgery in the treatment of stage I adult granulosa cell and Sertoli-Leydig cell tumors: (LARGES): Gynecologic oncology research investigators collaboration study (GORILLA-3005)
|
Jimin Lee (Ajou University) |
|
| 13:07-13:10 | Discussion | ||
| 13:10-13:17 | Clinicopathological characters, immunotherapy efficacy and oncological outcomes of gastric-type endocervical adenocarcinoma
|
Ming Du (Peking Union Medical College Hospital) |
|
| 13:17-13:20 | Discussion | ||
| 13:20-13:27 | Is it safe to reserve uterus after live-birth following fertility-sparing treatment of endometrial cancer and atypical hyperplasia: A long-term retrospective cohort study
|
Yiqin Wang (Peking University People's Hospital) |
|
| 13:27-13:30 | Discussion | ||
| 13:30-13:37 | Cell-free and concentrated ascites reinfusion therapy (CART) shows enhanced efficacy in gynecological cancer patients: A post-marketing surveillance study
|
Nami Tamura (Juntendo University) |
|
| 13:37-13:40 | Discussion | ||
| 13:40-13:47 | Early detection of malignancy, and identify key molecules involved in ovarian tumor metastasis using plasma and saliva-derived exosomes in 90 cases
|
Yuichi Shoburu (The University of Tokyo) |
|
| 13:47-13:50 | Discussion | ||
| 13:50-13:57 | When pathology diverges: Investigating discrepancies between original and review diagnoses in cervical cancer and precancer
|
Nida Jareemit (Mahidol University) |
|
| 13:57-14:00 | Discussion | ||
| 14:00-14:07 | Prevalence and factors associated with discrepancies between original and review pathology examinations in referral cases of premalignant and malignant endometrial lesions
|
Jira-Bhadhra WongwathanvikromI (Mahidol University) |
|
| 14:07-14:10 | Discussion | ||
| 14:10-14:17 | The role of radical mastectomy on breast metastasis from ovarian high grade serous carcinoma origin: A rare case report
|
Gerald Sebastian Davis (Universitas Indonesia) |
|
| 14:17-14:20 | Discussion | ||
| SESSION Nursing Session (Kor.) | Young Soo Chu (Korea University Anam Hospital) Woong Ju (Ewha Womans University) |
||
| 14:40-14:55 | The latest treatment for gynecologic cancer: Immuno-oncologic drug
|
Nam Kyeong Kim (Korea University) |
|
| 14:55-15:00 | Floor discussion | ||
| 15:00-15:15 | Management of immuno-oncologic drug side effects
|
Joo Hyun Kim (Samsung Medical Center) |
|
| 15:15-15:20 | Floor discussion | ||
| 15:20-15:35 | Radiation therapy and side effect management in gynecologic cancer patients
|
Hye Sung Moon (Ewha Wonams University Mokdong Hospital) |
|
| 15:35-15:40 | Floor discussion | ||
| 15:40-15:55 | Pathologic and genetic testing in gynecologic cancer patients
|
Soo Hyun Oh (Gachon University) |
|
| 15:55-16:00 | Floor discussion | ||
| April 26 (Sat) Hall D | |||
| 08:30-16:10 | E-Poster Exhibition | Hall D | |
| PE-01 | NIR-II fluorescence imaging based on Trop-2-targeting peptide guides precise resection of abdominal metastases from ovarian cancer | Chengxi LI (Xiamen University) |
|
| PE-02 | Development of a blood cell analysis-based AI model for early detection of ovarian cancer (Withdrawal) | Se Ik Kim (Seoul National University Hospital) |
|
| PE-03 | Prevalence of homologous recombination deficiency in Korean patients with epithelial ovarian cancer | Junhwan Kim (National Cancer Center) |
|
| PE-04 | Clinical and molecular characteristics of patients with high-grade serous ovarian cancer recurring on PARP inhibitors | Hyun Park (CHA Bundang Medical Center) |
|
| PE-05 | Mortality rate changes related to trends in the use of neoadjuvant chemotherapy in ovarian cancer in south korea: an analysis using national cancer registry data | Jun-Hyeong Seo (Samsung Medical Center) |
|
| PE-06 | Screening of germline variants using tumor multigene panel in gynecological cancer (Withdrawal) | Kidong Kim (Seoul National University Bundang Hospital) | |
| PE-07 | Drug repurposing of biguanides: exploring the anti-cancer effects of phenformin and metformin in epithelial ovarian cancer | Jihye Kim (Chung-Ang University Hospital) |
|
| PE-08 | Genomic analysis of PARP inhibitor response in high-grade serous ovarian cancer: Insights from whole genome sequencing (Withdrawal) | Ok-Ju Kang (Ulsan University Hospital) |
|
| PE-09 | The gene expression signature of niraparib treatment in HRP ovarian cancer cells | Zhong Zheng (Fudan University Shanghai Cancer Center) |
|
| PE-10 | The role of Gonadotropin-releasing hormone 2 in epithelial ovarian cancer | Eun-Ju Lee (Chung-Ang University Hospital) |
|
| PE-11 | Comprehensive analysis of germline variants and clonal hematopoiesis in Ovarian Cancer patients using whole exome sequencing | Hye-Lim Cho (Incheon National University) |
|
| PE-12 | cfDNA fragmentation signatures and a novel framework for epigenome-dependent analysis: Potential application in HRD and signature 3 (Withdrawal) | Yoo-Na Kim (Harvard Medical School) |
|
| PE-13 | Development and validation of a blood-based high-Specificity PCR algorithm for diagnosis of ovarian cancer (Withdrawal) | Se Ik Kim (Seoul National University Hospital) |
|
| PE-14 | Development of a next generation sequencing cancer panel-based homologous recombination deficiency test in epithelial ovarian cancer (Withdrawal) | Se Ik Kim (Seoul National University Hospital) |
|
| PE-15 | Clinical and genetic predictive factors of PARP inhibitor efficacy in advanced or recurrent ovarian cancer | In Sun Hwang (Seoul ST. Mary’s Hospital) |
|
| PE-16 | Preoperative MRI metrics as predictor of progression-free survival in epithelial ovarian cancer | Heekyoung Song (Incheon ST. Mary’s Hospital) |
|
| PE-17 | Metabolomic and transcriptomic analyses identify metabolic alterations and immune suppression in ovarian cancer | Maiko Yamaguchi (National Cancer Center Research Institute) |
|
| PE-19 | Postoperative systemic immune-inflammatory index (SII) as a prognostic factor in Epithelial ovarian cancer | Young Eun Chung (Samsung Medical Center) |
|
| PE-20 | A retrospective study of 11 cases from a single institution: malignant transformation arising from mature cystic teratoma | Minseong Choi (Inje University Haeundae Paik Hospital) |
|
| PE-21 | Optimizing hIPEC protocols: Preventive approaches for cisplatin-Induced AKI in ovarian cancer | Jimin Lee (Ajou University Medical Center) |
|
| PE-22 | The association between location of BRCA mutation and efficacy of PARP inhibitor as a frontline maintenance therapy in advanced epithelial ovarian cancer | Ji Hyun Kim (National Cancer Center) |
|
| PE-23 | Comparative efficacy of Olaparib and niraparib in maintenance therapy for brca-mutated epithelial ovarian cancer: A real-world survival analysis | Yae-Sol Kim (Seoul Asan Medical Center) |
|
| PE-24 | Treatment results using PARP inhibitors for advanced ovarian cancer～From our hospital data～ | Miseon Nakazawa (NTT Medical Center Sapporo) |
|
| PE-25 | ESRP1-Mediated alternative splicing in ovarian cancer: Insights from RNA splicing analysis and evolutionary patterns in tumor cells | Xihan Liu (Qilu Hospital Shandong University) |
|
| PE-26 | Clinical and survival outcomes of controlled suction technique with minimal spillage in the patients presented with huge ovarian cyst | Nam Kyeong Kim (Korea University Ansan Hospital) |
|
| PE-27 | Survival analysis of high grade serous ovarian cancer using tumor infiltrating lymphocytes and tumor mutational burden | Sun Joo Lee (Samsung Medical Center) |
|
| PE-28 | Characterization of interleukin-6 signaling pathways in BRCA-mutated ovarian cancer | Eun Ji Lee (Seoul National University Hospital) |
|
| PE-29 | Adjuvant chemotherapy after complete surgical staging in early-stage ovarian clear cell carcinoma: necessity or overtreatment? | Jihyun Lee (Yonsei University Severance Hospital) |
|
| PE-30 | Tumor microenvironmental heterogeneity in ovarian clear cell carcinoma revealed by spatial transcriptomics | Yu Rim Lee (Yonsei University Severance Hospital) |
|
| PE-31 | Clinical significance of homologous recombination deficiency in non-BRCA mutated ovarian cancer | So Jin Shin (Seoul National University Bundang Hospital) |
|
| PE-32 | A multi-institutional study on survival outcomes in advanced ovarian cancer patients treated with dose-dense chemotherapy | Eun Ji Choi (Chungnam National University Hospital) |
|
| PE-33 | Genomic landscape of ovarian carcinosarcoma and comparison with high-grade serous carcinoma | Min Ji Song (National Cancer Center) |
|
| PE-34 | The role of PAX8 in ovarian cancer metastasis: from transcriptional regulation to therapeutic potential | Yeon Hee Park (Kyungpook National University Chilgok Hospital) |
|
| PE-35 | Prognostic impact of immune-related gene signatures in ovarian cancer patients receiving immune checkpoint inhibitors | Mina Park (Seoul National University Hospital) |
|
| PE-36 | Clinicopathologic features and outcomes of early versus late recurrence in advanced-stage ovarian cancer | Jae Eun Chung (Seoul St. Mary’s Hospital) |
|
| PE-37 | Analysis of ctDNA as a predictive biomarker for platinum resistance in ovarian cancer | Hye Min Jeong (National Cancer Center) |
|
| PE-38 | The role of exosomes in promoting angiogenesis in epithelial ovarian cancer | Seo Yeon Park (Korea University Guro Hospital) |
|
| PE-39 | Predictive value of neutrophil-to-lymphocyte ratio in advanced ovarian cancer treated with neoadjuvant chemotherapy | Sung Hee Kim (Inje University Busan Paik Hospital) |
|
| PE-40 | Single-cell RNA sequencing reveals immune cell landscape in high-grade serous ovarian cancer | Jung Min Lee (Asan Medical Center) |
|
| PE-41 | BRCA1/2 reversion mutations and resistance to PARP inhibitors in ovarian cancer | Bo Young Kim (Seoul National University Hospital) |
|
| PE-42 | Impact of HIPEC on recurrence patterns in advanced epithelial ovarian cancer | Soo Min Kim (Konkuk University Medical Center) |
|
| PE-43 | Comparative study of laparoscopic versus open interval debulking surgery in advanced ovarian cancer | Hyun Jung Lee (Ewha Womans University Mokdong Hospital) |
|
| PE-44 | Long-term survival outcomes in ovarian cancer patients with BRCA mutations receiving maintenance olaparib | Mi Kyung Kim (Samsung Medical Center) |
|
| PE-45 | Tumor budding as a prognostic marker in serous ovarian carcinoma | Yoon Ji Choi (Chonnam National University Hwasun Hospital) |
|
| PE-46 | Epigenetic regulation of chemoresistance in ovarian clear cell carcinoma | Hye Young Lee (Pusan National University Hospital) |
|
| PE-47 | Clinical outcomes of ovarian cancer patients undergoing fertility-sparing surgery | Ji Eun Park (Ajou University Hospital) |
|
| PE-48 | Serum HE4 levels as a marker for recurrence in epithelial ovarian cancer | Soo Jin Lee (Hanyang University Hospital) |
|
| PE-49 | Comparative analysis of treatment outcomes in young vs elderly ovarian cancer patients | Na Young Kim (Seoul St. Mary's Hospital) |
|
| PE-50 | Evaluation of preoperative imaging modalities for accurate staging in ovarian cancer | Min Ji Kang (Inje University Sanggye Paik Hospital) |
|
| PE-51 | Prognostic significance of ascites cytology in advanced stage ovarian cancer | Hye Bin Lee (Chungnam National University Hospital) |
|
| PE-52 | Survival outcomes of patients with ovarian cancer and synchronous endometrial cancer | So Yeon Park (Dongguk University Ilsan Hospital) |
|
| PE-53 | Immune checkpoint expression in ovarian cancer and correlation with clinical outcomes | Eun Jung Kim (Kyungpook National University Chilgok Hospital) |
|
| PE-54 | Utility of next-generation sequencing in recurrent ovarian cancer management | Sun Young Yoon (Korea University Anam Hospital) |
|
| PE-55 | Risk-reducing salpingo-oophorectomy outcomes in BRCA mutation carriers | Ji Hye Lee (Keimyung University Dongsan Hospital) |
|
| PE-56 | Quality of life assessment in ovarian cancer survivors: a multicenter study | Min Jung Kim (Soonchunhyang University Hospital) |
|
| PE-57 | Corded and hyalinized endometrioid endometrial carcinoma: A rare case treated with robot-assisted surgery | Su Jeong Lee (Uijeongbu ST. Mary’s Hospital) |
|
| PE-58 | Examination of the functions and mechanism of KCP in mediating paclitaxel resistance in cervical squamous carcinoma cells | Yue He (Beijing Obstetrics and Gynecology Hospital) |
|
| PE-59 | ZBTB5 enhances the resistance of cervical cancer to paclitaxel by regulating BCL6 | Yue He (Beijing Obstetrics and Gynecology Hospital) |
|
| PE-60 | Establishment of a risk prediction model for predicting cervical lesions in HR-HPV positive women based on host six-gene methylation | Bin Li (Shaanxi Provincial People) |
|
| PE-61 | Persistent inflammation and abnormal finding in physical exam: Surgical decisions in persistent high-risk HPV infections without HSIL results | Hyun Jin Choi (Chung-Ang University Hospital) |
|
| PE-62 | The significance of HPV 18 in neuroendocrine carcinoma of the cervix (Withdrawal) | Se Ik Kim (Seoul National University Hospital) |
|
| PE-63 | Association between underlying comorbidities and the risk of cervical cancer: A retrospective cohort study in the South Korea | Yongwook Kim (Incheon ST. Mary’s Hospital) |
|
| PE-64 | Hematopoietic stem cell-containing autologous blood transfusion for bone marrow protection in patients with cervical cancer | Na Zhang (Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital) |
|
| PE-65 | A comparative study of cervicovaginal microbiome in women with or without human papillomavirus infection. | Kavita Khoiwal (AIIMS Rishikesh) |
|
| PE-66 | Excessive carbohydrate Intake associated with higher risk of cervical cancer in Korea : Korean national health and nutrition examination survey 2016-2021 | Seon Mi Lee (Korea University Anam Hospital) |
|
| PE-67 | The impact of physical activity on mortality among women with cervical cancer | Young Eun Chung (Samsung Medical Center) |
|
| PE-68 | Cervical HPV prevalence and analysis of human leukocyte antigen among women with hematologic malignancies | Min Jin Jeong (Eunpyeong St. Mary’s Hospital) |
|
| PE-69 | Kielin chordin protein as a biomarker predicting chemo-resistance in cervical cancer to paclitaxel | Chen Ji (Beijing Obstetrics and Gynecology Hospital) |
|
| PE-70 | Prognostic analysis of patients with locally advanced cervical cancer undergoing radical hysterectomy | Yong Zhao (Qilu Hospital of Shandong University) |
|
| PE-71 | Assessment of reproductive outcomes of patients with early-stage (IA1-IB1) cervical cancer after repeated conization versus single conization | Beihua Kong (Qilu Hospital of Shandong University) |
|
| PE-72 | Risk factors for high-grade squamous intraepithelial lesion recurrence after the two-layer loop electrosurgical excision procedure in patients with positive endocervical, exocervical, and deep margins | In Sun Hwang (Seoul ST. Mary’s Hospital) |
|
| PE-73 | Mixed neuroendocrine tumor of the cervix has a poorer prognosis than pure neuroendocrine tumor (NECXT) (Withdrawal) | Kidong Kim (Seoul National University Bundang Hospital) |
|
| PE-74 | A case of cervical carcinoma with perforation of pyometra of the uterus | Kengo Hiranuma (JUNTENDO University) |
|
| PE-75 | Results of treatment for FIGO stage I-II vulvar squamous cell carcinoma at Viet Nam National cancer Hospital. | Anh Nguyen (Vietnam National Cancer Hospital) |
|
| PE-76 | Real-world efficacy and survival of PD-1/PD-L1 monoclonal antibody-based immunotherapy in cervical cancer. | Xinran Li (Peking Union Medical College Hospital) |
|
| PE-77 | Sensitivity prediction to uterine artery interventional chemoembolization in locally advanced cervical cancer with MRI-based radiomics | Bin Li (Shaanxi Provincial People's Hospital) |
|
| PE-78 | Assessment of preoperative ultrasound for predicting the feasibility of minimally invasive surgery in early-stage cervical cancer: A pilot study | Kyung Jin Eoh (Yongin Severance Hospital) |
|
| PE-79 | Effect of using McCartney tube to reduce tumor spillage during minimally invasive radical hysterectomy for cervical cancer | Seongmin Kim (Korea University Anam Hospital) |
|
| PE-80 | Comparative analysis of laparoscopic, robotic-assisted, and abdominal radical hysterectomy for early-stage cervical cancer: A 22-year retrospective study | Changmin Shin (Keimyung University Dongsan Medical Center) |
|
| PE-81 | Silk-based nanoparticle for enhanced paclitaxel delivery and targeted anticancer therapy in cervical cancer | Jung Hwan Ahn (Wonju Severance Christian Hospital) |
|
| PE-82 | Normalization of posttreatment squamous cell carcinoma antigen (SCC Ag) as a prognostic marker in patients with advanced cervical cancer treated with first-line bevacizumab–paclitaxel–cisplatin therapy | Haa-Na Song (Gyeongsang National University Hospital) |
|
| PE-83 | Construction and validation of a prognostic prediction model for aggressive histotype endometrial carcinoma | Beihua Kong (Qilu Hospital of Shandong University) |
|
| PE-84 | Marker discovery of serum circulating metabolites distinguishing CIN from normal for cervical cancer prevention | Eunjung Yang (Soonchunhyang University Hospital Cheonan) |
|
| PE-85 | Prognostic impact of positive margins after LEEP in patients with cervical intraepithelial neoplasia | Changmin Shin (Keimyung University Dongsan Medical Center) |
|
| PE-86 | Detection of microbial infections and antibiotic resistance within 90 minutes in urine and blood samples of symptomatic patients with paper-based electrochemical DNA biosensor | Kavita Khoiwal (AIIMS Rishikesh) |
|
| PE-87 | Indocyanine green vs. methylene blue: A comparative study on sentinel lymph node detection in early-stage endometrial cancer | Rahima Nazarova (National Oncology Center) |
|
| PE-88 | Changes of disease spectrum of malignant tumor of female reproductive system in Beijing Obstetrics and Gynecology Hospital in recent 60 years | Yue He (Beijing Obstetrics and Gynecology Hospital) |
|
| PE-89 | Treatment of radiation-induced vaginal stenosis using the martius-symmonds flap | Ilnur Musin (Bashkir State Medical University) |
|
| PE-90 | An international prospective comparative study on articulating laparoscopic instruments in benign adnexal gynecologic surgery | Young Eun Chung (Samsung Medical Center) |
|
| PE-91 | Genomic and transcriptomic profiling of Lynch Syndrome patients with unaffected carrier status, premalignant lesion, and endometrial carcinoma | Yoo-Na Kim (Severance Hospital) |
|
| PE-92 | Feasibility exploration of constructing a patient derived tumor tissue xenograft (PDX) model for malignant tumors of the female reproductive system in mice | Yue He (Beijing Obstetrics and Gynecology Hospital) |
|
| PE-93 | A unique case of recurrent LCH involving the bilateral vulva | Na Zhang (Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital) |
|
| PE-94 | Impact of gut microbiota on immune checkpoint inhibitor efficacy in gynaecological cancers | Hyun Jin Choi (Chung-Ang University Hospital) |
|
| PE-95 | Radiofrequency ablation | Amartuvshin T1,2 TUMENJARGEL (Mongolia-Japan Teaching Hospital) |
|
| PE-96 | Primary peritoneal carcinoma mimicking advanced ovarian cancer | Kyongjin Kim (Presbyterian Medical Center) |
|
| PE-97 | Hysterectomy for benign gynecologic disease: A comparative study of articulating laparoscopic instruments and robot-assisted surgery in Korea and Taiwan | Jun-Hyeong Seo (Samsung Medical Center) |
|
| PE-98 | Feasibility of laparoscopic hysterectomy using an articulating laparoscopic instrument: A prospective observational study | Jun-Hyeong Seo (Samsung Medical Center) |
|
| PE-99 | Comparison of artisential and conventional laparoscopic instruments in hysterectomy for gynecologic cancers: A hybrid observational study on surgical outcomes, pain control, and oncologic safety | Seongyun Lim (Samsung Medical Center) |
|
| PE-100 | Application of the whole-course management model in patients with endometrial cancer or atypical hyperplasia undergoing fertility preservation | Yuanyuan Liu (Peking University People's Hospital) |
|
| PE-101 | Risk factors associated with residual lesions in subsequent hysterectomy after loop electrosurgical excision procedure | Minseong Choi (Inje University Haeundae Paik Hospital) |
|
| PE-102 | The impact of ME1 expression on tumor progression and immunotherapy in ovarian cancer: a comprehensive analysis | Jiahui Wei (Beijing Obstetrics and Gynecology Hospital) |
|
| PE-103 | A comprehensive mRNA-lncRNA signature predicts lymph node metastasis in cervical cancer patients | Jiahui Wei (Beijing Obstetrics and Gynecology Hospital) |
|
| PE-104 | Unexpected premalignant and malignant lesion of endometrium and ovary in fertility workup | Suresh Kayastha (Kathmandu Cancer Center) |
|
| PE-105 | Histology type profile of endometrial abnormalities: A five-year prevalence study | Insi Hidayatul Husna (Andalas University) |
|
| PE-106 | Analysis of histology type from uterine cervix biopsy in Padang: A five-year retrospective study | Wendy Armi (Faculty of Medicine, Andalas University) |
|
| PE-107 | Pathological examination overview of uterine tumors indicative of uterine cancer: A five-year retrospective study | M. Fikri Ridha (Andalas University) |
|
| PE-108 | Histology analysis of ovarian tumors: A five-year retrospective study in an Indonesian Regional Hospital | Kelsy Qoridisa (Andalas University) |
|
| PE-109 | High P63 expression associated with better survival outcome in FIGO stage IIIC1p cervical cancer | Jiao Wang (Beijing Obstetrics and Gynecology Hospital) |
|
| PE-110 | CASE report: Challenges in management of malignant mixed Mullerian tumour | Kathy Kathy (University of Medicine -2, Yangon) |
|
| PE-111 | Intraoperative mesenteric lymphatic mapping to prevent chylous leakage: A case report | Chowon Park (CHA University) |
|
